1. Home
  2. ANGI vs CMPX Comparison

ANGI vs CMPX Comparison

Compare ANGI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGI
  • CMPX
  • Stock Information
  • Founded
  • ANGI 1995
  • CMPX 2014
  • Country
  • ANGI United States
  • CMPX United States
  • Employees
  • ANGI N/A
  • CMPX N/A
  • Industry
  • ANGI Advertising
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANGI Consumer Discretionary
  • CMPX Health Care
  • Exchange
  • ANGI Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • ANGI 626.1M
  • CMPX 730.9M
  • IPO Year
  • ANGI 2017
  • CMPX N/A
  • Fundamental
  • Price
  • ANGI $11.23
  • CMPX $4.20
  • Analyst Decision
  • ANGI Hold
  • CMPX Strong Buy
  • Analyst Count
  • ANGI 8
  • CMPX 7
  • Target Price
  • ANGI $20.50
  • CMPX $14.43
  • AVG Volume (30 Days)
  • ANGI 916.6K
  • CMPX 1.8M
  • Earning Date
  • ANGI 11-04-2025
  • CMPX 11-05-2025
  • Dividend Yield
  • ANGI N/A
  • CMPX N/A
  • EPS Growth
  • ANGI 13.43
  • CMPX N/A
  • EPS
  • ANGI 0.72
  • CMPX N/A
  • Revenue
  • ANGI $1,057,636,000.00
  • CMPX N/A
  • Revenue This Year
  • ANGI N/A
  • CMPX N/A
  • Revenue Next Year
  • ANGI $4.89
  • CMPX N/A
  • P/E Ratio
  • ANGI $15.70
  • CMPX N/A
  • Revenue Growth
  • ANGI N/A
  • CMPX N/A
  • 52 Week Low
  • ANGI $10.88
  • CMPX $1.27
  • 52 Week High
  • ANGI $27.10
  • CMPX $4.86
  • Technical
  • Relative Strength Index (RSI)
  • ANGI 18.10
  • CMPX 58.66
  • Support Level
  • ANGI $12.95
  • CMPX $3.50
  • Resistance Level
  • ANGI $13.54
  • CMPX $3.95
  • Average True Range (ATR)
  • ANGI 0.52
  • CMPX 0.27
  • MACD
  • ANGI -0.15
  • CMPX -0.02
  • Stochastic Oscillator
  • ANGI 7.69
  • CMPX 90.85

About ANGI Angi Inc.

Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: